What is the main business of M Microbiotics?

The main business activity of M Microbiotics focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 8, 2020.

Where is the headquarters located?

The headquarters is located at: 64D, 21-008 Płouszowice-Kolonia.

Who is on the management board?

The management board consists of: Michał Marian Mazurkiewicz (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company's revenue reached $8.

No, in 2024 the company was not profitable, reporting a net loss of $159. For comparison, in 2023 the loss was $226, meaning the company reduced its loss by 33.2%.

M Microbioticssp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-09-08

Share capital

5,000.00 PLN

Registered address

64D, 21-008 Płouszowice-Kolonia, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 4 financial statements were filed late (the longest delay 517 days for 2023).

2025not filed
202415/02/2026
202314/12/2025
202222/11/2023
202122/11/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Research and experimental development on biotechnology356 / 386

Top 92%

Division · Scientific research and development1,839 / 1,952

Top 94%

Sector · Professional, scientific and technical activities37,862 / 39,196

Top 97%

Voivodeship · Lubelskie15,454 / 15,984

Top 97%

Country · Poland476,169 / 495,935

Top 96%

Results vs industry

Revenue

This companyUSD 7.52MedianUSD 55.66kAverageUSD 2.70m

Net profit

This companyUSD -158.93MedianUSD -1.27kAverageUSD -92.16k

Operating costs

This companyUSD 166.45MedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 1.46kMedianUSD 133.19kAverageUSD 3.03m

Industry

Research and experimental development on biotechnology (72.11.Z)Primary

Authorized Representatives

Michał Marian Mazurkiewiczage 50 – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Michał Marian Mazurkiewiczage 50	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-09-17 to 2022-09-27.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
BiotechnaS.A.	$2,472,888.07	bsbiotechna.com
FcbiotechS.A.	$148,945.77	fcbiotech.pl
Microbe Plussp. z o.o.	$104,197.26	microbe-plus.com
Vitagenumsp. z o.o.	$9,376.94	vitagenum.pl
Meritrosp. z o.o.	$7,890.74	meritro.com
Dairy Biotechnologiessp. z o.o.	$1,485.09	milcu.eu
Innervisionsp. z o.o.	$4.54	innervision.pl
ImmunotronicsP.S.A.	$0.16	immunotronics.net
Aiventrosp. z o.o.	$0.00	aiventro.com
Walletmed Heartsp. z o.o.	–	walletmed.com